ACOA Invests $2million in Orthpaedic Innovation

Andy Fillmore, Member of Parliament for Halifax, on behalf of the Atlantic Canada Opportunities Agency (ACOA) announced a $2 million investment for a NSHA orthopaedic project on Wednesday April 17th. 

Left to right: Dr. Travis McDonough (CEO & Founder Kinduct), Barbara Campbell (CEO OrthoMX), MP Andy Fillmore (MP for Halifax), Dr. Alex Fuentes (Chief Scientific & Technology Officer, Emovi), Dr. Michael Dunbar (Principal Investigator & Orthopaedic Surgeon), Dr. Gail Tomblin Murphy (VP Research & Innovation, NSHA)

Dr. Michael Dunbar and the orthopaedic research team, in conjunction with partners Kinduct, Emovi and OrthoMX, are seeking to advance the standard of care, increase treatment options and improve orthopaedic wait times.

NSHA puts a priority on translating research into clinical practice and this project will provide medical staff with enhanced information such that they can make more timely and precise decisions.

“Once again, we are drawing a straight line from research and innovation to improved patient outcomes. Nova Scotia Health Authority places a high priority on research and this particular project will advance the standard for patients who need orthopaedic care. We are very pleased to collaborate with industry partners to improve care for Nova Scotians.”
      - Janet Knox, President and CEO, Nova Scotia Health Authority

The technology involved is a three part partnership between Kinduct, Emovi and OrthoMX. Kinduct developed a platform for remote patient monitoring where patients can access information about their care and interact with their healthcare team. Emovi's KneeKG system is a wearable knee assessment device that assesses knee joint functions dynamically. OrthoMX uses the InStride app to track walking patterns. These three parts together will shape the new Mobility Assessment Clinic at the QEII Health Sciences Centre. 

“Today we see that meaningful collaboration fosters innovation. With the support of ACOA, our NSHA collaborative research partnership with Kinduct, Emovi and OrthoMX is bringing transformative innovations to patients across Nova Scotia.”
    - Dr. Michael Dunbar, Orthopaedic Surgeon, Endowed Chair of Arthroplasty Outcomes, Queen Elizabeth II Health Sciences Centre
 
Congratulations to Dr. Dunbar and the orthopaedic team!

2019 is the Year of Partnerships and Innovation

2019 is off to an exciting start for NSHA Research & Innovation. Dr. Steven Beyea and the team at BIOTIC is embarking on a new project that will enable the QEII Health Sciences Centre to be the first in Canada to have a point of care MRI in the emergency department. 

This new equipment is part of a collaboration between BIOTIC and Synaptive and was funded by ACOA ($700k) and the Research Nova Scotia Trust ($1.26M). Synaptive, in addition to being a technology partner, will also provide over $1.3M through in-kind contributions. 

This project highlights Nova Scotia as a centre for research and innovation on the international stage.  Patient outcomes will be studied for 3 years after the equipment is installed in September 2019. The equipment will put the right tools in the hands of clinicians who handle brain injuries. 

Please join us as we congratulate Dr. Beyea and the BIOTIC team. 

At the funding announcement (L to R):Dr. Colin Dodds, Alex Panther, Minister Kousoulis, Janet Knox, Dr. Steven Beyea, MP Andy Fillmore, Dr. Gail Tomblin Murphy